Global Alpha-fetoprotein (AFP) Tumor Market Research Report 2023

Publication ID:

PB504241634

Publication Date:

May 3, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Alpha-fetoprotein (AFP) Tumor market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Alpha-fetoprotein (AFP) Tumor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Alpha-fetoprotein (AFP) Tumor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Alpha-fetoprotein (AFP) Tumor in Screening and Early Detection is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Alpha-fetoprotein (AFP) Tumor include Abbott Laboratories, Labcorp, Roche Diagnostics, Thermo Fisher Scientific and MP Biomedicals, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Alpha-fetoprotein (AFP) Tumor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-fetoprotein (AFP) Tumor.
The Alpha-fetoprotein (AFP) Tumor market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Alpha-fetoprotein (AFP) Tumor market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha-fetoprotein (AFP) Tumor companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
Labcorp
Roche Diagnostics
Thermo Fisher Scientific
MP Biomedicals
Segment by Type
Liver Cancer
Testes Cancer
Ovarian Cancer
Others
Segment by Application
Screening and Early Detection
Diagnosis
Prognosis
Post Treatment Monitoring
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alpha-fetoprotein (AFP) Tumor companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-fetoprotein (AFP) Tumor Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Liver Cancer
1.2.3 Testes Cancer
1.2.4 Ovarian Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alpha-fetoprotein (AFP) Tumor Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Screening and Early Detection
1.3.3 Diagnosis
1.3.4 Prognosis
1.3.5 Post Treatment Monitoring
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha-fetoprotein (AFP) Tumor Market Perspective (2018-2029)
2.2 Alpha-fetoprotein (AFP) Tumor Growth Trends by Region
2.2.1 Global Alpha-fetoprotein (AFP) Tumor Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Alpha-fetoprotein (AFP) Tumor Historic Market Size by Region (2018-2023)
2.2.3 Alpha-fetoprotein (AFP) Tumor Forecasted Market Size by Region (2024-2029)
2.3 Alpha-fetoprotein (AFP) Tumor Market Dynamics
2.3.1 Alpha-fetoprotein (AFP) Tumor Industry Trends
2.3.2 Alpha-fetoprotein (AFP) Tumor Market Drivers
2.3.3 Alpha-fetoprotein (AFP) Tumor Market Challenges
2.3.4 Alpha-fetoprotein (AFP) Tumor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-fetoprotein (AFP) Tumor Players by Revenue
3.1.1 Global Top Alpha-fetoprotein (AFP) Tumor Players by Revenue (2018-2023)
3.1.2 Global Alpha-fetoprotein (AFP) Tumor Revenue Market Share by Players (2018-2023)
3.2 Global Alpha-fetoprotein (AFP) Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha-fetoprotein (AFP) Tumor Revenue
3.4 Global Alpha-fetoprotein (AFP) Tumor Market Concentration Ratio
3.4.1 Global Alpha-fetoprotein (AFP) Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-fetoprotein (AFP) Tumor Revenue in 2022
3.5 Alpha-fetoprotein (AFP) Tumor Key Players Head office and Area Served
3.6 Key Players Alpha-fetoprotein (AFP) Tumor Product Solution and Service
3.7 Date of Enter into Alpha-fetoprotein (AFP) Tumor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-fetoprotein (AFP) Tumor Breakdown Data by Type
4.1 Global Alpha-fetoprotein (AFP) Tumor Historic Market Size by Type (2018-2023)
4.2 Global Alpha-fetoprotein (AFP) Tumor Forecasted Market Size by Type (2024-2029)
5 Alpha-fetoprotein (AFP) Tumor Breakdown Data by Application
5.1 Global Alpha-fetoprotein (AFP) Tumor Historic Market Size by Application (2018-2023)
5.2 Global Alpha-fetoprotein (AFP) Tumor Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Alpha-fetoprotein (AFP) Tumor Market Size (2018-2029)
6.2 North America Alpha-fetoprotein (AFP) Tumor Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Alpha-fetoprotein (AFP) Tumor Market Size by Country (2018-2023)
6.4 North America Alpha-fetoprotein (AFP) Tumor Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha-fetoprotein (AFP) Tumor Market Size (2018-2029)
7.2 Europe Alpha-fetoprotein (AFP) Tumor Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Country (2018-2023)
7.4 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size (2018-2029)
8.2 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Region (2018-2023)
8.4 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alpha-fetoprotein (AFP) Tumor Market Size (2018-2029)
9.2 Latin America Alpha-fetoprotein (AFP) Tumor Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Country (2018-2023)
9.4 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size (2018-2029)
10.2 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Country (2018-2023)
10.4 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Alpha-fetoprotein (AFP) Tumor Introduction
11.1.4 Abbott Laboratories Revenue in Alpha-fetoprotein (AFP) Tumor Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Alpha-fetoprotein (AFP) Tumor Introduction
11.2.4 Labcorp Revenue in Alpha-fetoprotein (AFP) Tumor Business (2018-2023)
11.2.5 Labcorp Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Alpha-fetoprotein (AFP) Tumor Introduction
11.3.4 Roche Diagnostics Revenue in Alpha-fetoprotein (AFP) Tumor Business (2018-2023)
11.3.5 Roche Diagnostics Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Alpha-fetoprotein (AFP) Tumor Introduction
11.4.4 Thermo Fisher Scientific Revenue in Alpha-fetoprotein (AFP) Tumor Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 MP Biomedicals
11.5.1 MP Biomedicals Company Detail
11.5.2 MP Biomedicals Business Overview
11.5.3 MP Biomedicals Alpha-fetoprotein (AFP) Tumor Introduction
11.5.4 MP Biomedicals Revenue in Alpha-fetoprotein (AFP) Tumor Business (2018-2023)
11.5.5 MP Biomedicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott Laboratories
Labcorp
Roche Diagnostics
Thermo Fisher Scientific
MP Biomedicals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂